Sanofi-GSK’s COVID-19 vaccine enters EMA rolling review as the companies work on phase 3 trial

The continent’s drug regulator said Tuesday its human medicines committee has begun the real-time review based on lab studies and early clinical … Read source

Click to rate this post!
[Total: 0 Average: 0]
Scroll to Top